tiprankstipranks
Trending News
More News >
Innospec (IOSP)
:IOSP
US Market

Innospec (IOSP) Ratios

Compare
155 Followers

Innospec Ratios

IOSP's free cash flow for Q1 2025 was $0.28. For the 2025 fiscal year, IOSP's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.38 2.38 2.15 2.16 2.24
Quick Ratio
1.58 1.58 1.23 1.34 1.37
Cash Ratio
0.55 0.55 0.36 0.42 0.42
Solvency Ratio
0.32 0.32 0.32 0.26 0.18
Operating Cash Flow Ratio
0.56 0.56 0.20 0.28 0.58
Short-Term Operating Cash Flow Coverage
0.00 0.00 5.88 0.00 0.00
Net Current Asset Value
$ 438.00M$ 327.90M$ 309.30M$ 190.20M$ 113.70M
Leverage Ratios
Debt-to-Assets Ratio
0.03 0.03 0.03 0.02 0.03
Debt-to-Equity Ratio
0.04 0.04 0.04 0.03 0.04
Debt-to-Capital Ratio
0.04 0.04 0.04 0.03 0.04
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.03 0.02 0.00
Financial Leverage Ratio
1.49 1.49 1.54 1.52 1.48
Debt Service Coverage Ratio
0.00 0.00 9.05 93.87 45.11
Interest Coverage Ratio
0.00 0.00 170.27 88.07 45.89
Debt to Market Cap
0.00 0.00 0.02 0.01 0.00
Interest Debt Per Share
1.82 1.82 1.87 1.51 1.73
Net Debt to EBITDA
-1.09 -0.79 -0.54 -0.58 -0.70
Profitability Margins
Gross Profit Margin
30.33%30.33%29.88%29.32%28.72%
EBIT Margin
8.29%8.29%9.46%9.16%3.48%
EBITDA Margin
10.31%10.31%9.54%12.28%7.73%
Operating Profit Margin
8.29%8.29%9.54%8.91%6.92%
Pretax Profit Margin
8.95%8.95%9.40%9.06%3.33%
Net Profit Margin
7.14%7.14%6.77%6.28%2.41%
Continuous Operations Profit Margin
7.14%7.14%6.77%6.28%2.41%
Net Income Per EBT
79.76%79.76%72.05%69.27%72.29%
EBT Per EBIT
107.92%107.92%98.56%101.74%48.06%
Return on Assets (ROA)
2.05%8.15%8.29%5.93%2.05%
Return on Equity (ROE)
2.94%12.13%12.78%9.01%3.04%
Return on Capital Employed (ROCE)
13.05%12.10%15.64%10.70%7.21%
Return on Invested Capital (ROIC)
11.16%9.55%11.01%7.34%5.16%
Return on Tangible Assets
2.77%11.12%11.08%8.10%3.02%
Earnings Yield
1.30%4.54%5.22%4.18%1.29%
Efficiency Ratios
Receivables Turnover
5.42 5.42 5.87 5.21 5.39
Payables Turnover
8.30 8.30 8.33 7.05 8.62
Inventory Turnover
4.52 4.52 3.69 3.78 3.87
Fixed Asset Turnover
6.22 6.22 7.38 5.94 4.76
Asset Turnover
1.14 1.14 1.22 0.94 0.85
Working Capital Turnover Ratio
3.97 3.97 4.58 4.21 3.72
Cash Conversion Cycle
106.03 104.08 117.27 114.88 119.80
Days of Sales Outstanding
67.58 67.39 62.19 70.00 67.73
Days of Inventory Outstanding
84.35 80.68 98.90 96.64 94.43
Days of Payables Outstanding
45.90 43.98 43.82 51.76 42.36
Operating Cycle
151.93 148.07 161.09 166.64 162.16
Cash Flow Ratios
Operating Cash Flow Per Share
8.34 8.34 3.30 3.78 5.94
Free Cash Flow Per Share
5.24 5.24 1.59 2.19 4.73
CapEx Per Share
2.50 2.50 1.71 1.59 1.21
Free Cash Flow to Operating Cash Flow
0.63 0.63 0.48 0.58 0.80
Dividend Paid and CapEx Coverage Ratio
2.13 2.13 1.10 1.37 2.64
Capital Expenditure Coverage Ratio
3.34 3.34 1.93 2.38 4.91
Operating Cash Flow Coverage Ratio
4.59 4.59 1.80 2.62 3.58
Operating Cash Flow to Sales Ratio
0.11 0.11 0.04 0.06 0.12
Free Cash Flow Yield
5.21%4.25%1.55%2.43%5.21%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
22.02 22.02 19.17 23.92 77.65
Price-to-Sales (P/S) Ratio
1.57 1.57 1.30 1.50 1.87
Price-to-Book (P/B) Ratio
2.67 2.67 2.45 2.16 2.36
Price-to-Free Cash Flow (P/FCF) Ratio
23.54 23.54 64.71 41.16 19.18
Price-to-Operating Cash Flow Ratio
14.77 14.77 31.21 23.89 15.27
Price-to-Earnings Growth (PEG) Ratio
5.14 5.14 0.46 0.11 -1.04
Price-to-Fair Value
2.67 2.67 2.45 2.16 2.36
Enterprise Value Multiple
14.46 14.46 13.07 11.64 23.47
Enterprise Value
2.50B 2.90B 2.45B 2.12B 2.16B
EV to EBITDA
11.13 14.46 13.07 11.64 23.47
EV to Sales
1.35 1.49 1.25 1.43 1.81
EV to Free Cash Flow
17.47 22.32 62.13 39.19 18.62
EV to Operating Cash Flow
13.55 14.01 29.96 22.75 14.83
Tangible Book Value Per Share
27.89 27.89 25.68 24.80 20.29
Shareholders’ Equity Per Share
46.16 46.16 41.97 41.91 38.47
Tax and Other Ratios
Effective Tax Rate
0.20 0.20 0.28 0.31 0.28
Revenue Per Share
78.42 78.42 79.22 60.19 48.57
Net Income Per Share
5.60 5.60 5.37 3.78 1.17
Tax Burden
0.86 0.80 0.72 0.69 0.72
Interest Burden
0.23 1.08 0.99 0.99 0.96
Research & Development to Revenue
0.03 0.02 0.02 0.03 0.03
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
5.18 1.49 0.61 1.00 5.08
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis